Methicillin-resistant and susceptible Staphylococcus aureus: tolerance, immune evasion and treatment
Top Cited Papers
- 20 August 2025
- journal article
- review article
- Published by Springer Nature in Nature Reviews Microbiology
- Vol. 24 (2) , 127-145
Abstract
Staphylococcus aureus is capable of infecting every organ system in the body and developing resistance to every available antibiotic used to treat it, such as methicillin-resistant S. aureus (commonly referred to as MRSA). This pathogen is characterized by the sudden emergence of virulent new clones and an array of mechanisms to circumvent the immune system and antibiotics. Furthermore, despite the development of new antibiotics and a growing body of high-quality data to inform their use, S. aureus continues to be a leading bacterial cause of death worldwide. In this Review, we provide an overview of the basic research on the complex interplay between S. aureus, the host and antibiotics. We also provide an update on the contemporary clinical studies on the treatment and prevention of S. aureus.Keywords
This publication has 213 references indexed in Scilit:
- Dalbavancin for Treatment of Staphylococcus aureus BacteremiaJAMA, 2025
- Rifampin-accompanied antibiotic regimens in the treatment of prosthetic joint infections: a frequentist and Bayesian meta-analysis of current evidenceEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- Staphylococci evade the innate immune response by disarming neutrophils and forming biofilmsFEBS Letters, 2020
- Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA BacteremiaJAMA, 2020
- Clinical Implications of Vancomycin Heteroresistant and Intermediately Susceptible Staphylococcus aureusPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2015
- Clinical Management ofStaphylococcus aureusBacteremiaJAMA, 2014
- Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureusJournal of Molecular Medicine, 2013
- Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic SurgeryJAMA, 2013
- High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Safety of Patients Isolated for Infection ControlJAMA, 2003